Trial Profile
A study of LTX-109 in mildly infected diabetic foot ulcers
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 18 Apr 2018
Price :
$35
*
At a glance
- Drugs LTX 109 (Primary)
- Indications Diabetic foot ulcer
- Focus Therapeutic Use
- 18 Apr 2018 New trial record